Lifeboat Foundation

A new study by researchers at the University of Cambridge reveals a surprising discovery that could transform the future of electrochemical devices. The findings offer new opportunities for the development of advanced materials and improved performance in fields such as energy storage, brain-like computing, and bioelectronics.

Electrochemical devices rely on the movement of charged particles, both ions and electrons, to function properly. However, understanding how these charged particles move together has presented a significant challenge, hindering progress in creating new materials for these devices.

In the rapidly evolving field of bioelectronics, soft conductive materials known as conjugated polymers are used for developing medical devices that can be used outside of traditional clinical settings. For example, this type of materials can be used to make wearable sensors that monitor patients’ health remotely or implantable devices that actively treat disease.

There are many different definitions of aging, but scientists generally agree upon some common features: Aging is a time-dependent process that results in increased vulnerability to disease, injury and death. This process is both intrinsic, when your own body causes new problems, and extrinsic, when environmental insults damage your tissues.

Your body is comprised of trillions of cells, and each one is not only responsible for one or more functions specific to the tissue it resides in, but must also do all the work of keeping itself alive. This includes metabolizing nutrients, getting rid of waste, exchanging signals with other cells and adapting to stress.

The trouble is that every single process and component in each of your cells can be interrupted or damaged. So your cells spend a lot of energy each day preventing, recognizing and fixing those problems.

Dr. ryan brinkman-vice president and research director, dotmatics

Scientists have long been perceived and portrayed in films as old people in white lab coats perched at a bench full of bubbling fluorescent liquids. The present-day reality is quite different. Scientists are increasingly data jockeys in hoodies sitting before monitors analyzing enormous amounts of data. Modern-day labs are more likely composed of sterile rows of robots doing the manual handling of materials, and lab notebooks are now electronic, in massive data centers holding vast quantities of information. Today, scientific input comes from data pulled from the cloud, with algorithms fueling scientific discovery the way Bunsen burners once did.

Advances in technology, and especially instrumentation, enable scientists to collect and process data at an unprecedented scale. As a result, scientists are now faced with massive datasets that require sophisticated analysis techniques and computational tools to extract meaningful insights. This also presents significant challenges—how do you store, manage, and share these large datasets, as well as ensure that the data is of high quality and reliable?

A dazzlingly fast chatbot cannot replace the authentic and reflective voice of a thinking, living human being.

It squats on the Las Vegas skyline like an enormous spaceship, black and mysterious – until night falls, when it will glow like the Earth from space.

The MSG Sphere won’t open to the public for almost three more months, when U2 christens the entertainment venue with a series of concerts. But anticipation is growing.

Continue reading “This futuristic concert venue in Las Vegas is a giant sphere with the world’s biggest LED screen” »

Real-time tumor profiling can guide surgical, treatment decisions.

The first endovascular neural interface, the Stentrode™ is a minimally invasive implantable brain device that can interpret signals from the brain for patients with paralysis. Implanted via the jugular vein, the #Stentrode is placed inside the #brain in the command-control center, known as the motor cortex, but without the need for open brain surgery. The signals are captured and sent to a wireless unit implanted in the chest, which sends them to an external receiver. We are building a software suite that enables the patient to learn how to control a computer operating system and set of applications that interact with assistive technologies. This #technology has the potential to enable patients with paralysis to take back digital control of their world, without having to move a muscle.

Synchron is currently preparing for pilot clinical trials of the Stentrode™ to evaluate the safety and efficacy of this breakthrough technology.

Continue reading “Synchron Stentrode: Brain Computer Interface for Paralysis” »

Fight fibromyalgia fatigue, pain, and stress with these tips from WebMD. See how to get the rest you need, talk with your family, get energy from exercise, and more.

Duke University Science and Technology scholar Trudy Oliver, Ph.D, has made progress with small cell lung cancer by systematically profiling it. For the past 30 years, all patients with the disease have been treated the same, with chemotherapy. In the last handful of years, Oliver and other researchers have shown that they can divide the disease into at least four different subtypes, each of which responds differently to treatment.